The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

AbbVie today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib (RINVOQ®;15 mg, once daily  in adult and adolescent patients ...

Cervomed Inc. (($CRVO)) announced an update on their ongoing clinical study. Study Overview: Cervomed Inc. is currently recruiting for a clinical ...

Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer ...

Amicus Therapeutics (FOLD) remains a Buy, driven by strong product momentum and new assets. Read here for more investment ...

ARBs are typically used to treat high blood pressure, heart failure, and chronic kidney disease. Learn how they work, their benefits, and their side effects. Angiotensin II receptor blockers (ARBs) ...

Enzyme mechanisms are the chemical transformations, and the steps within them, generated by enzymatic action on substrates. The mechanism of enzyme catalysis is similar in principle to other types of ...

The enzyme PARP1 helps repair single-stranded DNA breaks, and its inhibition shows antitumor efficacy in ovarian, breast, prostate and pancreatic cancers involving mutations in BRCA1 or BRCA2. However ...